Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of MK-0724 in middle cerebral artery ischemic stroke
2008-002079-28Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ischemic stroke comparing MK-0724 infusion with Placebo infusion (2 arms). Primary endpoint: Primary: Day 90 Action Research Arm Test (ARAT) score. Started Jun 2008; status: terminated.
02
Drugs
arundic acid
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2008-002079-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002079-28.